Stocksigma LogoStocksigma Logo

Avience Biomedicals Confirms Corporate Governance Non-Applicability For Q2 FY27

Avience Biomedicals Limited notified the National Stock Exchange on 28th Oct'26 that corporate governance compliance provisions under SEBI (LODR)

Avience Biomedicals Confirms Corporate Governance Non-Applicability For Q2 FY27

Avience Biomedicals Ltd 路 Others (Uncategorized) 路 29 Oct 2026, 12:23 am

Avience Biomedicals Confirms Corporate Governance Non-Applicability For Q2 FY27 Avience Biomedicals Limited notified the National Stock Exchange on 28th Oct'26 that corporate governance compliance provisions under SEBI (LODR) Regulations, 2015 are not applicable to the company for the quarter ended 30th Sep'26. As an entity listed on the NSE Emerge SME platform, the company is exempt under Regulation 15(2)(b), thereby removing the requirement to submit quarterly corporate governance reports. The filing was supported by a certification from practicing company secretary firm G.R. Gupta & Associates.

Original exchange filing (PDF)

More announcements from Avience Biomedicals Ltd

All Avience Biomedicals Ltd announcements